Page last updated: 2024-11-05

ticlopidine and Mitral Valve Insufficiency

ticlopidine has been researched along with Mitral Valve Insufficiency in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Polzin, A1
Afzal, S1
Balzer, J1
Rassaf, T1
Kelm, M1
Zeus, T1

Other Studies

1 other study available for ticlopidine and Mitral Valve Insufficiency

ArticleYear
Platelet reactivity in MitraClip patients.
    Vascular pharmacology, 2016, Volume: 77

    Topics: Aspirin; Clopidogrel; Cohort Studies; Heart Valve Prosthesis Implantation; Hemorrhage; Ischemia; Mit

2016